NBD AI Bulletin, Guangzhou Wondfo Biotech Co., Ltd. (the Company, SZ 300482, closing price: 84.76 yuan) announced on September 25 that the Company received a notification from controlling shareholders, Mr. Li Wenmei and Ms. Wang Jihua. Mr. Li Wenmei and Ms. Wang Jihua on September 23, 2020 and September 24, reduced about 2.17 million of the Company's convertible bonds via block trading through the Shenzhen Stock Exchange. The number accounts for 36.18% of the total amount of convertible bonds issued this time.

Guangzhou Wondfo Biotech Co., Ltd.'s chairman is Wang Jihua, 58 years old, Chinese national, no permanent residence abroad, graduated from the National Laboratory of Enzyme Engineering, Jilin University, master's degree. Guangzhou Wondfo Biotech Co., Ltd.'s general manager is Li Wenmei, male, 58 years old, Chinese national, no permanent residence abroad, master's degree.

Tips on "Stock Trends":

1. The number of shares held by northbound investors increased by 19,700 in the past 30 days, representing 0.01% of the Company's circulating shares.

2.One batch of institutions (9 in total) conducted research on the Company in the past 30 days. 

3. The last reduction announcement of AGuangzhou Wondfo Biotech Co., Ltd. was issued on July 24, 2020, and the stock rose 1.84% on the following trading day. The Company issued a total of 14 such announcements in the past 12 months.

(By Li Menglin)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.